Webinar

This webinar is hosted by Amyloidosis Support Group. In this chapter of the webinar Mathew S. Maurer, MD, Cardiologist, Director, Cardiac Amyloidosis Center, Professor of Medicine, Columbia University Medical Center; Nitasha Sarswat, MD, Director of Infiltrative Cardiomyopathy Program, University of Chicago Medicine; Lynn Punnoose, MD, Director, Vanderbilt Advanced Heart Failure/Transplant Fellowship Program, Vanderbilt University Medical […]

Amyloidosis Support Groups ATTR Amyloidosis Webinar, July 15, 2023. The webinar included a Q&A discussion on Attralus Trials and Diflunisal Use.

Amyloidosis Support Groups’ webinar for light chain (AL) amyloidosis patients and caregivers in the Northeast region on September 18, 2021. Led by ASG President Muriel Finkel, this webinar discusses the current treatments for light chain amyloidosis and features amyloidosis expert: Cara Rosenbaum, MD, Hematologist/Oncologist and Assistant Professor of Medicine, Weill Cornell Medical College, New York,

Amyloidosis Support Groups’ webinar for light chain (AL) amyloidosis was hosted on January 15, 2022. Led by ASG President Muriel Finkel, this webinar discusses the current treatments for light chain amyloidosis and features amyloidosis expert: Ansgar Conrad, PhD, VP, Medical Affairs & Patient Advocacy, Prothena Biosciences, Inc., South San Francisco, CA

Presented by Jeffrey A. Zonder, MD – Professor from the Department of Oncology at the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine.

Amyloidosis Support Groups’ webinar for light chain (AL) amyloidosis patients and caregivers in the Northeast region on September 18, 2021. Led by ASG President Muriel Finkel, this webinar discusses the current treatments for light chain amyloidosis and features amyloidosis expert: Heather J. Landau, MD, Hematologic Oncologist at Memorial Sloan Kettering Cancer Center, New York, NY.

Dr. Adam Castano, Sr. Medical Director for ATTR Cardiac Amyloidosis at Pfizer, presents an update on Vyndaqel/Vyndamax (Tafamidis), Pfizer’s TTR stabilizer treatment, at ASG’s 12/05/2020 ATTR webinar.

Amyloidosis Support Groups webinar on AL amyloidosis from October 29, 2022. Led by ASG President Muriel Finkel, featured speaker Rajshekhar Chakraborty, MD, Assistant Professor of Medicine, Columbia University Medical Center, Multiple Myeloma and Amyloidosis Service, New York, NY, talks about Phase 1/2 Trial of Venetoclax.

Amyloidosis Support Groups webinar on ATTR amyloidosis from July 23, 2022. Led by ASG President Muriel Finkel, featured speakers Craig Spolsky, Advocacy & Professional Relations Director, Pfizer, Inc. and Chris Olson, Senior Director, Vyndamax Access & Patient Solutions, Pfizer, Inc., talks abut Pfizer Update. Source: Amyloidosis Support Group https://www.youtube.com/watch?v=acad9kqTtfw&t=9349s Amyloidosis Support Groups webinar on ATTR

ASG’s Northeastern regional webinar on ATTR amyloidosis, recorded on July 10, 2021. The webinar is presented by: Thomas Brannagan, MD, Director, Peripheral Neuropathy Center, Professor of Neurology, Columbia University Vagelos College of Physicians and Surgeons.